COVID-19 Pfizer Information


X

Thank you for finding us at EAU 2022

Who We Are and What We Do

​​​​​​​One way or another, cancer touches all of our lives. That is why nothing is more personal, or more urgent, than our goal to find new treatments for these deadly diseases


Thank you for finding us at EAU 2022

Who We Are and What We Do

​​​​​​​One way or another, cancer touches all of our lives. That is why nothing is more personal, or more urgent, than our goal to find new treatments for these deadly diseases

Upcoming Opportunities to Connect

Symposia

Evolving Concepts in Metastatic Prostate Cancer
Date: July 1, 2022
Time: 19:30 - 20:30 CEST

Add To Calendar


​​​​​​​Oral Presentations

First line avelumab in PD-L1+ve metastatic or locally advanced Urothelial Cancer (aUC) patients unfit for cisplatin: The ARIES trial
Presentation: A0906
Presenter: RI Iacovelli
Abstract Session: Advanced bladder cancer: Staging, predicting factors and systemic therapy
Location: Yellow Area, Room Forum
​​​​​​​Abstract Session Date and Time: Sunday, July 3, 2022; 15:45 – 17:15 CEST

Add To Calendar

Connect with Pfizer

Please fill out the form below. A member from the team will respond accordingly.

By providing your email address, you agree to receive an email response from Pfizer to your inquiry. Your email address will only be used to respond to your inquiry. The information you submit will be governed by our Privacy Policy.

All fields marked with an asterisk ( *) are required.

Thank you for
contacting Pfizer.

A team member will respond to your inquiry.

Satellite Symposium

Evolving Concepts in Metastatic Prostate Cancer

Add To Calendar

Evolving Concepts in Metastatic Prostate Cancer

View Link

Highlights From Your Congress





Prostate Virtual Session


What’s Of Interest



Focus on Health Equity

Tile-3
Tile-3
Tile-3

Tile-4
Tile-3
Tile-3
Tile-3

Tile-4
Tile-3
Tile-3
Tile-3

Tile-4

Investigator Information and How to Contact Us

Tile-5

Get it Done - Cancer Screening Campaign

Pfizer Oncology Collaborating to Improve Patient Centricity

Commitment To Oncology


Supporting Our Patients

Scheduled Events

Symposium


Evolving Concepts in Metastatic Prostate Cancer
Date: July 1, 2022
Time: 19:30 - 20:30 CEST

​​​​​​​Oral Presentations


First line avelumab in PD-L1+ve metastatic or locally advanced Urothelial Cancer (aUC) patients unfit for cisplatin: The ARIES trial
Presentation: A0906
Presenter: RI Iacovelli
Abstract Session: Advanced bladder cancer: Staging, predicting factors and systemic therapy
Location: Yellow Area, Room Forum
Abstract Session Date and Time: Sunday, July 3, 2022;
15:45 – 17:15 CEST

Learn About Our Oncology Approved Medicines
​​​​​​​

X

PF-06863135 is an investigational compound and has not been approved by any Regulatory Authority as safe or effective for any use. The preclinical and in vitro evidence presented here may not necessarily correlate with clinical outcomes.